Stay updated on Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study locations list was updated to reflect 56 sites, with additions across multiple countries and removals of several previously listed sites.
    Difference
    3%
    Check dated 2026-03-16T06:36:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T01:13:26.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no visible changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T14:09:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.0 to v3.4.1; no study details or user-facing functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T05:56:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated page metadata to include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-25T00:57:19.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4 with no changes to the clinical study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:44:35.000Z thumbnail image

Stay in the know with updates to Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.